Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Krishna Institute of Medical Sciences Limited (KIMS) operates a network of hospitals across India, focusing on high-quality healthcare services. Its competitive position is bolstered by a strong brand reputation and a diverse range of specialties, including cardiology, orthopedics, and oncology, primarily in urban centers like Hyderabad and Vishakhapatnam.
KIMS generates revenue primarily through inpatient and outpatient services, leveraging its established brand to command higher pricing in urban markets. The company benefits from economies of scale, allowing it to maintain a gross margin of 54.6%, while its extensive network facilitates cross-referrals among specialties.
Patient admission rates in key hospitals, particularly in Hyderabad
Expansion into new geographical markets, such as tier-2 cities
Regulatory changes affecting healthcare pricing and reimbursement
Technological advancements in medical treatments and diagnostics
Regulatory changes impacting healthcare delivery and pricing
Technological disruption from telemedicine and outpatient care models
Emergence of new healthcare providers in urban markets
Price competition from established players and new entrants
High debt levels could strain liquidity in adverse conditions
Potential pension obligations impacting cash flow
high - KIMS's revenue is closely tied to consumer spending on healthcare, which tends to decline during economic downturns.
Higher interest rates could increase KIMS's financing costs for capital expenditures, potentially impacting expansion plans and profitability.
minimal - KIMS's operations are not heavily reliant on credit, but high debt levels (Debt/Equity of 1.89) could pose risks if credit conditions tighten.
growth - KIMS's rapid revenue growth (30% YoY) and expansion potential appeal to growth-focused investors.
high - The stock has exhibited significant price fluctuations, as evidenced by a 35.8% return over the past three months.
